{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:24:50Z","timestamp":1777893890820,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:00:00Z","timestamp":1757203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["Y-Q201801-048"],"award-info":[{"award-number":["Y-Q201801-048"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2020xkj165"],"award-info":[{"award-number":["2020xkj165"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EXPLORE"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.explore.2025.103260","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:57:13Z","timestamp":1757170633000},"page":"103260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Traditional Chinese medicine combined with biologic therapy for refractory severe ulcerative colitis: A case report"],"prefix":"10.1016","volume":"21","author":[{"given":"Pengfei","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingdian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10401","key":"10.1016\/j.explore.2025.103260_bib0001","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.explore.2025.103260_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3349\/ymj.2021.62.2.99","article-title":"Incidence and prevalence of inflammatory bowel disease across Asia","volume":"62","author":"Park","year":"2021","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.explore.2025.103260_bib0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-023-04417-6","article-title":"Trends in the prevalence and incidence of ulcerative colitis in Japan and the US","volume":"38","author":"Yamazaki","year":"2023","journal-title":"Int J Colorectal Dis"},{"issue":"10114","key":"10.1016\/j.explore.2025.103260_bib0004","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.explore.2025.103260_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.explore.2025.103260_bib0006","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA Clinical Practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.explore.2025.103260_bib0007","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2020.01.007","article-title":"AGA technical review on the management of moderate to severe ulcerative colitis","volume":"158","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.explore.2025.103260_bib0008","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.explore.2025.103260_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196292","article-title":"Benefits and challenges of treat-to-target in inflammatory bowel disease","volume":"12","author":"West","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.explore.2025.103260_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO Guidelines on therapeutics in ulcerative colitis: surgical treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.explore.2025.103260_bib0011","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cgh.2018.06.031","article-title":"Effect of accelerated Infliximab induction on short- and long-term outcomes of acute severe ulcerative colitis: a retrospective multicenter study and meta-analysis","volume":"17","author":"Nalagatla","year":"2019","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"6","key":"10.1016\/j.explore.2025.103260_bib0012","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/flgastro-2020-101407","article-title":"Infliximab in acute severe colitis: getting the right dose","volume":"11","author":"Fiske","year":"2020","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"10.1016\/j.explore.2025.103260_bib0013","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12906-021-03387-y","article-title":"An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis","volume":"21","author":"Sun","year":"2021","journal-title":"BMC complement Med Ther"},{"issue":"1","key":"10.1016\/j.explore.2025.103260_bib0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13020-022-00591-x","article-title":"Chinese herbal medicines in the treatment of ulcerative colitis: a review","volume":"17","author":"Zhang","year":"2022","journal-title":"Chin Med"},{"issue":"4","key":"10.1016\/j.explore.2025.103260_bib0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2017.11.024","article-title":"Efficacy of Indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis","volume":"154","author":"Naganuma","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.explore.2025.103260_bib0016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cgh.2023.05.023","article-title":"Curcumin-QingDai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial","volume":"22","author":"Ben-Horin","year":"2024","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"9","key":"10.1016\/j.explore.2025.103260_bib0017","article-title":"Efficacy and safety of berberine plus 5-ASA for ulcerative colitis: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2024","journal-title":"PLoS One"},{"issue":"09","key":"10.1016\/j.explore.2025.103260_bib0018","first-page":"1029","article-title":"Guidelines for integrated Traditional Chinese and Western Medicine treatment of ulcerative colitis","volume":"44","year":"2024","journal-title":"Chin J Integr Tradit West Med"},{"issue":"6","key":"10.1016\/j.explore.2025.103260_bib0019","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","article-title":"ACG Clinical Guideline update: ulcerative Colitis in adults","volume":"120","author":"Rubin","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.explore.2025.103260_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14060580","article-title":"Current management of acute severe ulcerative colitis: new insights on the surgical approaches","volume":"14","author":"Lauricella","year":"2024","journal-title":"J Pers Med"},{"issue":"5","key":"10.1016\/j.explore.2025.103260_bib0021","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2006.09.039","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"131","author":"Moss","year":"2006","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.explore.2025.103260_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13247723","article-title":"Future of acute severe ulcerative colitis-A narrative review","volume":"13","author":"Pillay","year":"2024","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.explore.2025.103260_bib0023","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ueg2.12442","article-title":"Review article: updated management of acute severe ulcerative colitis: from steroids to novel medical strategies","volume":"11","author":"Calm\u00e9jane","year":"2023","journal-title":"United Eur Gastroenterol J"},{"issue":"30","key":"10.1016\/j.explore.2025.103260_bib0024","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.12998\/wjcc.v12.i30.6358","article-title":"Enhancing ulcerative colitis treatment with traditional Chinese medicine","volume":"12","author":"Hao","year":"2024","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.explore.2025.103260_bib0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.phrs.2016.07.015","article-title":"Pharmacokinetics interactions of monoclonal antibodies","volume":"111","author":"Ferri","year":"2016","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.explore.2025.103260_bib0026","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/head.14135","article-title":"A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management","volume":"61","author":"Joshi","year":"2021","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.explore.2025.103260_bib0027","doi-asserted-by":"crossref","first-page":"99","DOI":"10.11622\/smedj.2021173","article-title":"Ulcerative colitis: STRIDE-ing beyond symptoms with new standards","volume":"65","author":"Tay","year":"2024","journal-title":"Singap Med J"},{"key":"10.1016\/j.explore.2025.103260_bib0028","article-title":"Management of non-response and loss of response to anti-tumor necrosis factor therapy in inflammatory bowel disease","volume":"9","author":"Marsal","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["EXPLORE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155083072500151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155083072500151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:04:34Z","timestamp":1777619074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155083072500151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S155083072500151X"],"URL":"https:\/\/doi.org\/10.1016\/j.explore.2025.103260","relation":{},"ISSN":["1550-8307"],"issn-type":[{"value":"1550-8307","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional Chinese medicine combined with biologic therapy for refractory severe ulcerative colitis: A case report","name":"articletitle","label":"Article Title"},{"value":"EXPLORE","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.explore.2025.103260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103260"}}